News - Page 137 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory

Post published:November 15, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Deconstructing COMPASS Pathways’ Phase 2b Results

Psychedelic Bulletin: Deconstructing COMPASS Pathways’ Phase 2b Results

Post published:November 15, 2021
Post category:Psychedelic Bulletin

Read more about the article PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

Post published:November 11, 2021
Post category:Press Release

Read more about the article Silo Pharma Reports Third Quarter Results and Operating Highlights

Silo Pharma Reports Third Quarter Results and Operating Highlights

Post published:November 11, 2021
Post category:Press Release

Read more about the article Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’ Veterans & Families Forum on November 10, 2021

Mydecine’s Chief Medical Officer, Dr. Rakesh Jetly, to Participate at Horizons’ Veterans & Families Forum on November 10, 2021

Post published:November 10, 2021
Post category:Press Release

Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials

Post published:November 10, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Entheon Biomedical Announces Recruitment Underway in EBIQ-101 Clinical Study

Post published:November 10, 2021
Post category:Press Release

Read more about the article Nova Mentis Files Genetic Neuroinflammatory Disease Patent

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

Post published:November 9, 2021
Post category:Press Release

Read more about the article MYND Executes LOI to Enter into a Clinical Research Collaboration with Revitalist

MYND Executes LOI to Enter into a Clinical Research Collaboration with Revitalist

Post published:November 9, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021

Post published:November 9, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.